30230477|t|Protective Effects of Oleuropein Against Cerebral Ischemia/Reperfusion by Inhibiting Neuronal Apoptosis.
30230477|a|BACKGROUND In this study, we investigated the potential neuroprotective effect of oleuropein (OLE) on apoptotic changes via modulating Akt/glycogen synthase kinase 3 beta (Akt/GSK-3b) signaling in a rat model of cerebral ischemia/reperfusion injury (IRI). MATERIAL AND METHODS Sprague-Dawley male rats (12 weeks, n=200) were randomly assigned to 5 groups: sham group, vehicle (IRI+ vehicle) group, OLE (IRI+OLE) group, OLE+LY294002 (IRI+OLE+LY294002) group, and LY294002(IRI+LY294002) group. The rats were subjected to cerebral ischemia/reperfusion injury (IRI) model and treated once daily for 5 days with vehicle and OLE (100 mg/kg via intraperitoneal injection) after IRI injury. LY294002 (0.3 mg/kg) was intraperitoneally injected once at 30 min after IRI injury. Brain edema, neurological deficit, rotarod latencies, and Morris water maze (MWM) performance were evaluated after IRI. The number of dead cells were assayed by TUNEL staining. Western blot was used to detect the expression of Bcl-2, Bax, cleaved caspase-3 (CC3), neurotrophic factors, and the phosphorylation levels of Akt and GSK-3beta. RESULTS Compared with the vehicle group, brain water content, neurological deficits, rotarod latencies, and escape latency following IRI were reduced in the OLE group. Cell apoptosis and reduced neurotrophic factor caused by IRI was also attenuated by OLE. Furthermore, increased p-Akt and decreased p-GSK-3beta were caused by OLE, which were associated with decrease of Bax/Bcl-2 ratio and the suppression of Caspase-3 activity after IRI. Importantly, all the beneficial effects of OLE in the vehicle group were abrogated by PI3K inhibitor LY294002. CONCLUSIONS Cerebral ischemia was protected by OLE via suppressing apoptosis through the Akt/GSK-3beta pathway and upregulating neurotrophic factor after IRI.
30230477	22	32	Oleuropein	Chemical	MESH:C002769
30230477	41	58	Cerebral Ischemia	Disease	MESH:D002545
30230477	187	197	oleuropein	Chemical	MESH:C002769
30230477	199	202	OLE	Chemical	MESH:C002769
30230477	240	243	Akt	Gene	24185
30230477	244	275	glycogen synthase kinase 3 beta	Gene	84027
30230477	277	280	Akt	Gene	24185
30230477	281	287	GSK-3b	Gene	84027
30230477	304	307	rat	Species	10116
30230477	317	353	cerebral ischemia/reperfusion injury	Disease	MESH:D015427
30230477	355	358	IRI	Disease	MESH:D015427
30230477	402	406	rats	Species	10116
30230477	482	485	IRI	Disease	MESH:D015427
30230477	503	506	OLE	Chemical	MESH:C002769
30230477	508	511	IRI	Disease	MESH:D015427
30230477	512	515	OLE	Chemical	MESH:C002769
30230477	524	527	OLE	Chemical	MESH:C002769
30230477	528	536	LY294002	Chemical	MESH:C085911
30230477	538	541	IRI	Disease	MESH:D015427
30230477	542	545	OLE	Chemical	MESH:C002769
30230477	546	554	LY294002	Chemical	MESH:C085911
30230477	567	575	LY294002	Chemical	MESH:C085911
30230477	576	579	IRI	Disease	MESH:D015427
30230477	580	588	LY294002	Chemical	MESH:C085911
30230477	601	605	rats	Species	10116
30230477	624	660	cerebral ischemia/reperfusion injury	Disease	MESH:D015427
30230477	662	665	IRI	Disease	MESH:D015427
30230477	724	727	OLE	Chemical	MESH:C002769
30230477	776	786	IRI injury	Disease	MESH:D015427
30230477	788	796	LY294002	Chemical	MESH:C085911
30230477	861	871	IRI injury	Disease	MESH:D015427
30230477	873	884	Brain edema	Disease	MESH:D001929
30230477	886	906	neurological deficit	Disease	MESH:D009461
30230477	988	991	IRI	Disease	MESH:D015427
30230477	1100	1105	Bcl-2	Gene	24224
30230477	1107	1110	Bax	Gene	24887
30230477	1120	1129	caspase-3	Gene	25402
30230477	1193	1196	Akt	Gene	24185
30230477	1201	1210	GSK-3beta	Gene	84027
30230477	1274	1295	neurological deficits	Disease	MESH:D009461
30230477	1345	1348	IRI	Disease	MESH:D015427
30230477	1369	1372	OLE	Chemical	MESH:C002769
30230477	1407	1426	neurotrophic factor	Gene	81737
30230477	1437	1440	IRI	Disease	MESH:D015427
30230477	1464	1467	OLE	Chemical	MESH:C002769
30230477	1494	1497	Akt	Gene	24185
30230477	1514	1523	GSK-3beta	Gene	84027
30230477	1539	1542	OLE	Chemical	MESH:C002769
30230477	1583	1586	Bax	Gene	24887
30230477	1587	1592	Bcl-2	Gene	24224
30230477	1622	1631	Caspase-3	Gene	25402
30230477	1647	1650	IRI	Disease	MESH:D015427
30230477	1695	1698	OLE	Chemical	MESH:C002769
30230477	1753	1761	LY294002	Chemical	MESH:C085911
30230477	1775	1792	Cerebral ischemia	Disease	MESH:D002545
30230477	1810	1813	OLE	Chemical	MESH:C002769
30230477	1852	1855	Akt	Gene	24185
30230477	1856	1865	GSK-3beta	Gene	84027
30230477	1891	1910	neurotrophic factor	Gene	81737
30230477	1917	1920	IRI	Disease	MESH:D015427
30230477	Cotreatment	MESH:C002769	MESH:C085911
30230477	Association	24224	84027
30230477	Association	24887	84027
30230477	Association	24185	24224
30230477	Negative_Correlation	25402	84027
30230477	Association	24185	24887
30230477	Negative_Correlation	MESH:C002769	MESH:D015427
30230477	Negative_Correlation	MESH:C002769	24887
30230477	Association	MESH:D002545	84027
30230477	Association	24185	25402
30230477	Negative_Correlation	MESH:C002769	MESH:D009461
30230477	Association	MESH:C002769	24185
30230477	Negative_Correlation	MESH:C002769	84027
30230477	Association	MESH:D002545	24185
30230477	Negative_Correlation	MESH:C002769	81737
30230477	Negative_Correlation	MESH:D015427	81737
30230477	Association	MESH:D002545	81737
30230477	Negative_Correlation	MESH:C085911	MESH:D015427
30230477	Negative_Correlation	MESH:C002769	24224
30230477	Negative_Correlation	MESH:C002769	25402
30230477	Negative_Correlation	MESH:C002769	MESH:D002545

